You are here

Global & Regional Health Technology Assessment

Global & Regional Health Technology Assessment

Italian; Northern Europe and Spanish

Editor-in-Chief - Italian Journal
Dr Claudio Jommi Università del Piemonte Orientale, Italy
Editor-in-Chief - English Journal
Dr Aileen Murphy University College Cork, Ireland
Editor-in-Chief - Spanish Journal
Dr Alvaro Hidalgo Universidad de Castilla-La Mancha, Spain
Co-Editor - Italian Journal
Dr Roberto Ravasio Health Publishing & Services, Italy


eISSN: 22835733 | ISSN: 22842403 | Current volume: 2018 | Current issue: 1

Global and Regional Health Technology Assessment, is an international, peer-reviewed, open access journal focusing on promoting health technology assessment and economic evaluation, enabling choices among alternative therapeutical paths or procedures with different clinical and economic outcomes. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Why publish in Global and Regional Health Technology Assessment?

  • Rigorous peer review of your research
  • Multidisciplinary audience
  • Prompt online publication
  • Open access format, driving high visibility and global exposure

Open access article processing charge (APC) information

The APC for this journal is currently 1500 USD, discounted from the full rate of 2000 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/grhta

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Contact

Please direct any queries to:

Italian language section: Dr Claudio Jommi: Claudio.jommi@uniupo.it or Dr Roberto Ravasio rravasio@aboutphrama.com
English Language Section: Dr Aileen Murphy: aileen.murphy@ucc.ie
Spanish Language Section: Dr Alvaro Hidalgo: Alvaro.Hidalgo@uclm.es

Global & Regional Health Technology Assessment (GRHTA) is a peer-reviewed, open access journal which aims to promote health technology assessment and economic evaluation, enabling choices among alternative therapeutical paths or procedures with different clinical and economic outcomes. GRHTA is a unique journal having three different editorial boards who focus on their respective geographical expertise.

Editorial Board Member - English Journal
Dr Peter Childs Swedish Institute for Health Economics, Sweden
Dr Christopher Fawsitt University of Bristol, UK
Professor Brenda Gannon University of Queensland , Australia
Dr Cynthia Iglesias University of York, UK
Professor Andrea Manca  
Professor Ciaran O'Neill National University of Ireland, Ireland
Professor Olivia Wu University of Glasgow, UK
Editorial Board Member - Italian Journal
Dr Baroukh Assael Azienda Ospedaliera Universitaria Integrata Verona, Italy
Dr Gianluca Baio University College of London, UK
Dr Enzo Ballatori Universita di L'Aquila, Italy
Dr Patrizia Berto LA-SER Group, Italy
Dr Americo Cicchetti Universita Cattolica del Sacro Cuore, Italy
Dr Mario Eandi Universita degli Studi di Torino, Italy
Dr Giovanni Fattore Universita L. Bocconi, Italy
Dr Roberto Gasparini Universita Degli Studi Di Genova, Italy
Dr Sergio Iannazzo SIHS Health Economics Consulting, Italy
Dr Carlo Lazzaro Health economist and research director, Italy
Dr Carlo Lucioni  
Dr Aldo Maggioni Associazione Nazionale Medici Cardiologi Ospedalieri, Italy
Dr Nello Martini CORE srl - Collaborative Outcome Research, Italy
Dr Francesco Saverio Mennini Center for Economic and International Studies (CEIS) - Economic Evaluation and HTA (EEHTA), Italy
Dr Andrea Messori Ente di Supporto Tecnico Amministrativo Regione Toscana, Italy
Dr Eva Pagano Universita degli Studi di Torino, Italy
Dr Angelo Palozzo Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Italy
Dr Franco Perrone Istituto Nazionale Tumori di Napoli, Italy
Dr Matteo Ruggeri Universita Cattolica del Sacro Cuore, Italy
Pierluigi Russo Agenzia italiana del farmaco, Italy
Dr Giovanna Scroccaro Universita di Padova, Italy
Dr Rosanna Tarricone Universita L. Bocconi, Italy
Editorial Board Member - Spanish Journal
Dr David Cantatero-Prieto Universitad de Cantabria, Spain
MSc Health Economics Arely Carmona Celgene Laboratories, Mexico
Dr Indalecio Corugedo de las Cuevas Universidad Complutense de Madrid, Spain
Dr Jordi Gol-Freixa Instituto de Salud Carlos III, Spain
Dr Carlos Polanco Bristol Myers Squibb, Spain
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • Directory of Open Access Journals (DOAJ)
  • EBSCO
  • ProQuest
  •  

    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
    4. Editorial policies
      4.1 Peer review policy
      4.2 Authorship
      4.3 Acknowledgements
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical trials
      4.8 Reporting guidelines
      4.9 Data
    5. Publishing policies
      5.1 Publication ethics
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplementary material
      6.4 Reference style
      6.5 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.4 ORCID
      7.5 Permissions
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Online publication
      8.3 Promoting your article
    9. Further information

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the journal’s submission site http://mc.manuscriptcentral.com/grhta to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.

    Only manuscripts of sufficient quality that meet the aims and scope of Global & Regional Health Technology Assessment will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    1. Open Access

    Global & Regional Health Technology Assessment is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

    Return to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.

    The article processing charge (APC) for this journal is currently 1500 USD.

    Return to top

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Global & Regional Health Technology Assessment, please ensure you have read the Aims & Scope.

    3.2 Article types

    Ethical statements: Mandatory statements for all submissions: All submissions to Global & Regional Health Technology Assessment should include a statement confirming that the submission meets each of the below criteria. In the case of a statement being not applicable, ‘not applicable’ or ‘n/a’ is insufficient, and an explanation must be provided. In these cases the Editors expect to see the details of the Ethics Committee or Review Board that waived approval, including names and institutions of the relevant committee or a brief explanation.  

    - Acknowledgements (see section 4.3)
    - Authorship (see section 4.2)
    - Funding (see section 4.4)
    - Availability of data and materials (see section 4.9)
    - Conflict of interest (see section 4.5)
    - Informed consent (see section 4.6)
    - Ethical approval (see section 4.6)
    - Human rights (see section 4.6)

    Original research articles

    Previously unpublished manuscripts, describing clinical, pre-clinical, epidemiological investigations, clinical trials, clinical observations, and other relevant investigations that are based on sound patient series, validated analytical methods, and appropriate statistical evaluation.

    Original research articles should be structured as follows: Structured abstract (including Background, Aim, Methods, Results, Conclusion), Introduction (clearly stating an objective or hypothesis), Methods (describing the study design and methods applied, including the study setting and dates, patients or participants with inclusion and exclusion criteria, and/or participation or response rates, or data sources, and how these were selected for the study), Results (describing the results of the study in context with the published literature and addressing study limitations), and Discussion (addressing relevant implications for clinical practice or health policy).

    Words: max 5000 (excluding figures and tables)
    Figures/Tables: max 8
    References: max 70

    Reviews

    Reviews can be submitted on topics that are within the aims and scope of the Journal. Containing the current state of knowledge or practice, integrating recent advances with accepted principles and practice, or summarizing and analyzing consensus view of controversial issues in knowledge of practice.

    Articles must be structured as follows: Structured abstract (including Background, Aim, Methods, Results, Conclusion), Introduction (including statement of aims and hypothesis), Methods (usually including participants, experimental design, experimental protocol, statistical methods), Results, Discussion (including conclusion).

    Words: max 5000 (excluding figures and tables)
    Figures/Tables: max 8
    References: 70

    Editorials

    The purpose of the editorials is to provide the reader with a balanced overview of relevant and up to date subjects concerning the Journal's aim or future direction. An abstract is required.

    Words: max 5000 (excluding figures and tables)
    Figures/Tables: max 8
    References: 70

    Point of View...

    A leading expert in the field reports their opinion on a controversial issue as requested by the Editor in Chief. An abstract is required.

    Words: max 5000 (excluding figures and tables)
    Figures/Tables: max 8
    References: max 70

    Short communications This article type reports of results from original researches. They must provide conclusive findings: preliminary observations or incomplete findings cannot be considered for publication. A structured abstract is required (including Background, Aim, Methods, Results, Conclusion).

    Words: max 2000 (excluding figures and tables)
    Figures/Tables: max 4
    References: max 35

    Correspondence Letters to the Editor are intended to present opinions or comments on articles published in the Journal. Letters are subject to abridgement and editing for style and content. An abstract is required.

    If you are the corresponding author of an article cited in a Letter to the Editor and receive an email invitation to comment on it, you must log in to the system, accept the invitation immediately, and then upload and submit your reply to the Editorial Office. The response must cite the title of the letter, e.g., “Response to (Title of Letter)”.

    Words: max 500 (excluding figures and tables)
    Figures/Tables: 1
    References: max 5

    3.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

    3.3.1 Making your article discoverable

    When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online

    Return to top

    4. Editorial policies

    4.1 Peer review policy

    Following a preliminary triage to eliminate submissions unsuitable for Global & Regional Health Technology Assessment all papers are sent out for review. The covering letter is important. To help the Editor in his preliminary evaluation, please indicate why you think the paper suitable for publication. If your paper should be considered for fast-track publication, please explain why.

    The journal’s policy is to have manuscripts reviewed by two expert reviewers. Global & Regional Health Technology Assessment utilizes a single-blind peer review process in which the reviewer’s name and information is withheld from the author. All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor-in-Chief who then makes the final decision.

    As part of the submission process you will be asked to provide the names of three peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).

    Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors. The list of authors should include all those who can legitimately claim authorship. This is all those who:

    • Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
    • Drafted the article or revised it critically for important intellectual content,
    • Approved the version to be published,
    • Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. 

    Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.  

    When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

     Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    4.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.

    It is not necessary to disclose use of language polishing services.

     Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    4.4 Funding

    Global & Regional Health Technology Assessment requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

    4.5 Declaration of conflicting interests

    It is the policy of Global & Regional Health Technology Assessment to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    For guidance on conflict of interest statements, please see the ICMJE recommendations.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    4.7 Clinical trials

    Global & Regional Health Technology Assessment endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    4.9 Data

    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Global & Regional Health Technology Assessment requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor(s) may consider limited embargoes on proprietary data. The editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at Gabriella.Anderson@sagepub.co.uk .

    Return to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

    5.1.1 Plagiarism

    Global & Regional Health Technology Assessment and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement.  Global & Regional Health Technology Assessment publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.

    Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.

    Return to top

    6. Preparing your manuscript

    6.1 Word processing formats

    The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    6.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines

    Figures supplied in color will appear in color online.

    6.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.

    6.4 Reference style

    Global & Regional Health Technology Assessment adheres to the SAGE Vancouver reference style. Please review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the SAGE Vancouver output file here.

    6.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Return to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    Visit http://mc.manuscriptcentral.com/grhta to login and submit your article online.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.

    7.3 Information required for completing your submission

    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

    The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

    If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage to learn more.

    7.5 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    Return to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been checked for SAGE Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.

    8.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will made available to the corresponding author via our editing portal SAGE Edit, or by email to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximize your article’s impact with Kudos.

    Return to top

    9. Further information

    Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Global & Regional Health Technology Assessment editorial office as follows:

     Gabriella Anderson Gabriella.Anderson@sagepub.co.uk

    Return to top